These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
306 related items for PubMed ID: 11480331
1. Progression of hydroxychloroquine retinopathy after discontinuation of therapy: case report. Wei LC, Chen SN, Ho CL, Kuo YH, Ho JD. Chang Gung Med J; 2001 May; 24(5):329-34. PubMed ID: 11480331 [Abstract] [Full Text] [Related]
2. [Severe chloroquine- and hydroxychloroquine-induced retinopathy]. Ingster-Moati I, Bui Quoc E, Crochet M, Orssaud C, Dufier JL, Roche O. J Fr Ophtalmol; 2006 Jun; 29(6):642-50. PubMed ID: 16885894 [Abstract] [Full Text] [Related]
4. Ocular toxicity of hydroxychloroquine. Yam JC, Kwok AK. Hong Kong Med J; 2006 Aug; 12(4):294-304. PubMed ID: 16912357 [Abstract] [Full Text] [Related]
5. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity. Aylward JM. J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333 [Abstract] [Full Text] [Related]
6. Hydroxychloroquine retinopathy. Weiner A, Sandberg MA, Gaudio AR, Kini MM, Berson EL. Am J Ophthalmol; 1991 Nov 15; 112(5):528-34. PubMed ID: 1951589 [Abstract] [Full Text] [Related]
7. [Antimalarial drug retinopathy]. Guiot A, Couturier M, Tebib JG, Abouaf L, Coury F. Rev Med Interne; 2018 May 15; 39(5):364-368. PubMed ID: 29496271 [Abstract] [Full Text] [Related]
8. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy. Michaelides M, Stover NB, Francis PJ, Weleber RG. Arch Ophthalmol; 2011 Jan 15; 129(1):30-9. PubMed ID: 21220626 [Abstract] [Full Text] [Related]
9. [The ERG contribution in early diagnosis of chloroquine and hydroxychloroquine maculopathy]. Karkanová M, Matusková V, Vlková E, Dosková H, Uhmannová R. Cesk Slov Oftalmol; 2010 Apr 15; 66(2):62-6. PubMed ID: 20925239 [Abstract] [Full Text] [Related]
10. Case Report: Hydroxychloroquine Retinopathy. Eldeeb M, Chan EW, Omar A. Optom Vis Sci; 2018 Jun 15; 95(6):545-549. PubMed ID: 29787487 [Abstract] [Full Text] [Related]
11. [Chloroquine/hydroxychloroquine: variability of retinotoxic cumulative doses]. Rüther K, Foerster J, Berndt S, Schroeter J. Ophthalmologe; 2007 Oct 15; 104(10):875-9. PubMed ID: 17653725 [Abstract] [Full Text] [Related]
12. Evaluation of toxic retinopathy caused by antimalarial medications with spectral domain optical coherence tomography. Cabral RTS, Klumb EM, Couto MINN, Carneiro S. Arq Bras Oftalmol; 2019 Oct 15; 82(1):12-17. PubMed ID: 30403262 [Abstract] [Full Text] [Related]
15. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging. Mititelu M, Wong BJ, Brenner M, Bryar PJ, Jampol LM, Fawzi AA. JAMA Ophthalmol; 2013 Sep 15; 131(9):1187-97. PubMed ID: 23887202 [Abstract] [Full Text] [Related]
19. Normalization of generalized retinal function and progression of maculopathy after cessation of therapy in a case of severe hydroxychloroquine retinopathy with 19 years follow-up. Salu P, Uvijls A, van den Brande P, Leroy BP. Doc Ophthalmol; 2010 Jun 15; 120(3):251-64. PubMed ID: 20397038 [Abstract] [Full Text] [Related]
20. Long-term course of chloroquine retinopathy after cessation of medication. Brinkley JR, Dubois EL, Ryan SJ. Am J Ophthalmol; 1979 Jul 15; 88(1):1-11. PubMed ID: 463998 [Abstract] [Full Text] [Related] Page: [Next] [New Search]